New Zealand markets closed

Sonoma Pharmaceuticals, Inc. (SNOA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.4800-0.0900 (-1.97%)
At close: 04:00PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2021
31/03/2020
31/03/2019
31/03/2018
Total revenue
14,521
18,629
18,936
18,970
16,658
Cost of revenue
10,025
12,070
10,603
10,090
9,348
Gross profit
4,496
6,559
8,333
8,880
7,310
Operating expenses
Research development
259
555
1,339
1,518
1,575
Selling general and administrative
9,059
9,453
13,665
18,620
19,924
Total operating expenses
9,318
10,008
15,004
20,138
21,499
Operating income or loss
-4,822
-3,449
-6,671
-11,258
-14,189
Interest expense
-
12
16
33
40
Total other income/expenses net
289
-457
3,812
-239
-357
Income before tax
-4,538
-3,902
-2,825
-11,340
-14,328
Income tax expense
718
713
121
458
0
Income from continuing operations
-5,256
-4,615
-2,946
-11,798
-14,328
Net income
-5,508
-3,950
-2,946
-11,798
-14,328
Net income available to common shareholders
-5,508
-3,950
-2,946
-11,798
-14,328
Basic EPS
-
-1.97
-1.99
-12.77
-28.44
Diluted EPS
-
-1.97
-1.99
-12.77
-28.44
Basic average shares
-
1,996
1,477
923.999
503.332
Diluted average shares
-
1,996
1,477
923.999
503.332
EBITDA
-
-3,663
-2,497
-10,854
-13,798